SEC Tracker
Get the app

Trinity Biotech TRIB

Trinity Biotech: Ownership stake disclosure (amended)

Schedule 13D/A on Trinity Biotech (TRIB), filed with the SEC on Nov 10, 2026, 8:00 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. Credit Fund III and Trinity Biotech amended credit agreement on Nov 6, 2026
  2. Term loan borrowing increased by $4.0 million
  3. Floor price for note reduced to $10.00 per ADS
  4. Warrant exercise price amended to $5.90 per ADS

Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Trinity Biotech files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.